Healthcare Sector Struggles, Yet These Yields Reaching 7% Might Still Be Viable
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 29 2025
0mins
Should l Buy SILA?
Source: NASDAQ.COM
Healthcare Stocks Overview
- Market Performance: Healthcare stocks have remained stagnant since April, contrasting sharply with the S&P 500, which has surged by 27%. This stagnation has drawn the attention of contrarian investors looking for potential bargains or yield traps in the sector.
Key Healthcare Stocks
Omega Healthcare Investors (OHI): Offers a 6.4% yield and operates skilled nursing and assisted living facilities with a portfolio of 93,961 beds across over 1,000 properties. The company has shown recovery post-COVID, beating estimates for adjusted funds from operations (AFFO) and raising its full-year guidance. However, shares are trading at over 13 times next year's AFFO estimates, indicating a moderate valuation.
LTC Properties (LTC): With a 6.3% yield, LTC is transitioning some contracts to RIDEA-structured agreements, which could enhance growth potential. Currently, 7% of its enterprise value comes from this segment, with plans to double it by year-end.
Healthpeak Properties (DOC): This REIT has a 7.0% yield and a diverse portfolio including outpatient medical facilities and laboratories. The dividend was recently raised and converted to a monthly payout, but growth may be limited due to challenges in its life sciences segment.
Sila Realty Trust (SILA): A newer entrant with a 6.4% yield, SILA has delivered nearly 20% total returns since its IPO in June 2024. It has a solid financial position with long lease terms and a well-covered payout, although it reverted from a monthly to a quarterly dividend.
Pharmaceutical Sector Insights
Siga Technologies (SIGA): Offers a high yield of 7.1%, but is considered too concentrated as a single-drug company. Its future growth depends on diversification.
Bristol-Myers Squibb (BMY): A blue-chip pharmaceutical company with a market cap of nearly $100 billion and a 5.3% yield. Despite its diversified product line, BMY has underperformed, with a 25% decline in share price over five years. However, it recently beat earnings estimates and is forming strategic partnerships.
Pfizer (PFE): Currently yielding 6.9%, Pfizer has faced challenges, including the cancellation of a weight-loss drug trial and declining COVID-related sales. The company is targeting $7 billion in cost savings by 2027, but its dividend remains secure for now with a 55% payout ratio.
Investment Strategy
- Retirement Income Strategy: The article emphasizes the importance of generating income through dividends to avoid depleting capital in retirement. A proposed "No Withdrawal" portfolio could yield $40,000 annually from a $500,000 investment, highlighting the potential for high-yield investments to support retirement without touching the principal.
This analysis suggests that while healthcare stocks have been overlooked, there are opportunities for income-focused investors, particularly in REITs and select pharmaceutical companies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SILA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SILA
Wall Street analysts forecast SILA stock price to fall
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 30.580
Low
28.00
Averages
28.00
High
28.00
Current: 30.580
Low
28.00
Averages
28.00
High
28.00
About SILA
Sila Realty Trust, Inc. is a real estate investment trust. The Company is primarily focused on investing in high-quality healthcare facilities across the continuum of care, which the Company believes typically generates predictable, durable and growing income streams. Its portfolio comprises tenants in geographically diverse facilities, which are positioned to capitalize on the dynamic delivery of healthcare to patients. The Company owns approximately 136 real estate properties, and two undeveloped land parcels located in 66 markets across the United States. Its portfolio includes Akron Healthcare Facility, Alexandria Healthcare Facility, Allen Healthcare Facility, Appleton Healthcare Facility, Augusta Healthcare Facility, Beaumont Healthcare Facility, Bellevue Healthcare Facility, Carrollton Healthcare Facility, Cincinnati Healthcare Facility, Yukon Healthcare Facility, El Segundo Healthcare Facility, Dallas Healthcare Facility, Pleasant Hills Healthcare Facility, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sila Realty Trust Declares Quarterly Dividend of $0.40
- Quarterly Dividend Announcement: Sila Realty Trust declares a quarterly dividend of $0.40 per share, consistent with previous distributions, indicating the company's stable cash flow and shareholder return strategy, which is expected to bolster investor confidence.
- Dividend Yield: The forward yield of 5.23% makes this dividend attractive in the current market environment, potentially drawing in income-seeking investors and enhancing the company's competitive position within the Real Estate Investment Trust (REIT) sector.
- Financial Performance: Sila Realty Trust reports a GAAP EPS of $0.22 and revenue of $52.66 million, reflecting the company's ongoing growth potential in the high-yield healthcare real estate sector, despite facing AFFO headwinds, growth drivers are gradually aligning.
- Market Dynamics: The recent acquisition activities of Sila Realty Trust highlight that many REITs are still trading at a discount, potentially offering investors an opportunity to enter high-yield assets, further driving market interest in the company.
See More
Sila Realty Trust Q1 Financial Highlights
- Financial Performance: Sila Realty Trust reported Q1 AFFO of $0.61 and GAAP EPS of $0.22, with revenue reaching $52.66 million, indicating stable growth in the healthcare REIT sector.
- Cash Distributions: The company declared and paid cash distributions of $0.40 per share for the quarter, reflecting strong cash flow and commitment to shareholder returns, thereby enhancing investor confidence.
- Asset Acquisition: On January 15, 2026, the company acquired an inpatient rehabilitation facility in Oklahoma City for $43.3 million, marking a strategic expansion in its healthcare facility portfolio.
- Asset Sales: The company sold four healthcare facilities for a total of $25.1 million, generating net proceeds of $24.8 million after transaction costs, demonstrating proactive asset optimization and capital efficiency efforts.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE: SILA) for its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, raising concerns about potential shareholder rights violations and urging shareholders to explore their options.
- Esperion Transaction: Esperion Therapeutics, Inc. (NASDAQ: ESPR) is being sold to funds managed by ARCHIMED for $3.16 per share in cash, along with rights to contingent milestone payments, which may affect shareholder returns, prompting shareholders to understand their legal rights.
- Merger Details: Corebridge Financial, Inc. (NYSE: CRBG) is merging with Equitable Holdings, Inc., with Corebridge shareholders expected to own approximately 51% of the combined entity, highlighting the need for shareholders to assess the implications of the merger terms on their interests.
- Legal Advocacy: Halper Sadeh LLC represents investors globally, seeking increased consideration and additional disclosures for affected shareholders, emphasizing the firm's commitment to protecting shareholder interests and pursuing corporate accountability.
See More
Investigations into Multiple Biotech Company Mergers
- Esperion Acquisition Investigation: Esperion Therapeutics is set to be acquired by ARCHIMED for $3.16 per share in cash, with potential contingent milestone payments of up to $100 million, raising concerns about whether the board breached fiduciary duties by failing to ensure fair pricing for shareholders.
- Sila Realty Acquisition Scrutiny: Sila Realty Trust will be acquired by Blue Owl Capital for $30.38 per share in an all-cash deal valued at approximately $2.4 billion, with investigations questioning whether the board adequately protected shareholder interests during the transaction process, potentially affecting fair value.
- Lisata Therapeutics Merger Investigation: Lisata Therapeutics is being acquired by Kuva Labs for $4.00 per share in cash, along with two non-tradeable rights, prompting investigations into whether the board conducted a fair process, which could impact shareholder benefits.
- SkyWater Technology Acquisition Review: SkyWater is to be acquired by IonQ for $35.00 per share in a cash-and-stock deal valued at around $1.8 billion, with investigations focusing on whether the board fulfilled its fiduciary duties, particularly as the deal price is below the company's 52-week high of $36.27.
See More
Investor Rights Law Firm Investigates Sila Realty and Lisata Therapeutics
- Legal Investigation: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. and Lisata Therapeutics, Inc. to assess potential violations of federal securities laws in their transactions with Blue Owl Real Estate Capital and Kuva Labs, which may impact shareholder rights.
- Transaction Details: The sale price for Sila Realty is set at $30.38 per share, while Lisata's deal includes $4.00 per share plus two non-tradeable contingent value rights, terms that could limit superior competing offers and affect potential shareholder returns.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options, promising to provide legal services without upfront costs, aiming to secure increased consideration and additional disclosures for affected investors.
- Commitment to Legal Services: The firm represents investors globally, focusing on cases of securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, demonstrating their expertise in protecting investor rights.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Lisata Therapeutics, Inc. and Smithfield Foods, Inc., with Lisata shareholders expected to receive $4.00 per share in cash and potential contingent value rights, providing additional revenue opportunities for shareholders.
- Independent Bank Merger: In the merger between Independent Bank Corporation and HCB Financial Corp., HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 in cash per share, which will enhance Independent Bank's market position.
- Sila Realty Sale: In the transaction involving Sila Realty Trust, Inc. and Sunshine Ultimate Parent LLC, Sila Realty shareholders are expected to receive $30.38 in cash per share, delivering substantial cash returns to shareholders.
- Commitment to Legal Services: Monteverde Law Firm is recognized for its successful track record in securities class actions, emphasizing its ability to secure compensation for shareholders, thereby enhancing its competitive edge in the legal services market.
See More
Sila Realty Trust Declares Quarterly Dividend of $0.40
- Quarterly Dividend Announcement: Sila Realty Trust declares a quarterly dividend of $0.40 per share, consistent with previous distributions, indicating the company's stable cash flow and shareholder return strategy, which is expected to bolster investor confidence.
- Dividend Yield: The forward yield of 5.23% makes this dividend attractive in the current market environment, potentially drawing in income-seeking investors and enhancing the company's competitive position within the Real Estate Investment Trust (REIT) sector.
- Financial Performance: Sila Realty Trust reports a GAAP EPS of $0.22 and revenue of $52.66 million, reflecting the company's ongoing growth potential in the high-yield healthcare real estate sector, despite facing AFFO headwinds, growth drivers are gradually aligning.
- Market Dynamics: The recent acquisition activities of Sila Realty Trust highlight that many REITs are still trading at a discount, potentially offering investors an opportunity to enter high-yield assets, further driving market interest in the company.
See More
Sila Realty Trust Q1 Financial Highlights
- Financial Performance: Sila Realty Trust reported Q1 AFFO of $0.61 and GAAP EPS of $0.22, with revenue reaching $52.66 million, indicating stable growth in the healthcare REIT sector.
- Cash Distributions: The company declared and paid cash distributions of $0.40 per share for the quarter, reflecting strong cash flow and commitment to shareholder returns, thereby enhancing investor confidence.
- Asset Acquisition: On January 15, 2026, the company acquired an inpatient rehabilitation facility in Oklahoma City for $43.3 million, marking a strategic expansion in its healthcare facility portfolio.
- Asset Sales: The company sold four healthcare facilities for a total of $25.1 million, generating net proceeds of $24.8 million after transaction costs, demonstrating proactive asset optimization and capital efficiency efforts.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE: SILA) for its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, raising concerns about potential shareholder rights violations and urging shareholders to explore their options.
- Esperion Transaction: Esperion Therapeutics, Inc. (NASDAQ: ESPR) is being sold to funds managed by ARCHIMED for $3.16 per share in cash, along with rights to contingent milestone payments, which may affect shareholder returns, prompting shareholders to understand their legal rights.
- Merger Details: Corebridge Financial, Inc. (NYSE: CRBG) is merging with Equitable Holdings, Inc., with Corebridge shareholders expected to own approximately 51% of the combined entity, highlighting the need for shareholders to assess the implications of the merger terms on their interests.
- Legal Advocacy: Halper Sadeh LLC represents investors globally, seeking increased consideration and additional disclosures for affected shareholders, emphasizing the firm's commitment to protecting shareholder interests and pursuing corporate accountability.
See More
Investigations into Multiple Biotech Company Mergers
- Esperion Acquisition Investigation: Esperion Therapeutics is set to be acquired by ARCHIMED for $3.16 per share in cash, with potential contingent milestone payments of up to $100 million, raising concerns about whether the board breached fiduciary duties by failing to ensure fair pricing for shareholders.
- Sila Realty Acquisition Scrutiny: Sila Realty Trust will be acquired by Blue Owl Capital for $30.38 per share in an all-cash deal valued at approximately $2.4 billion, with investigations questioning whether the board adequately protected shareholder interests during the transaction process, potentially affecting fair value.
- Lisata Therapeutics Merger Investigation: Lisata Therapeutics is being acquired by Kuva Labs for $4.00 per share in cash, along with two non-tradeable rights, prompting investigations into whether the board conducted a fair process, which could impact shareholder benefits.
- SkyWater Technology Acquisition Review: SkyWater is to be acquired by IonQ for $35.00 per share in a cash-and-stock deal valued at around $1.8 billion, with investigations focusing on whether the board fulfilled its fiduciary duties, particularly as the deal price is below the company's 52-week high of $36.27.
See More
Investor Rights Law Firm Investigates Sila Realty and Lisata Therapeutics
- Legal Investigation: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. and Lisata Therapeutics, Inc. to assess potential violations of federal securities laws in their transactions with Blue Owl Real Estate Capital and Kuva Labs, which may impact shareholder rights.
- Transaction Details: The sale price for Sila Realty is set at $30.38 per share, while Lisata's deal includes $4.00 per share plus two non-tradeable contingent value rights, terms that could limit superior competing offers and affect potential shareholder returns.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options, promising to provide legal services without upfront costs, aiming to secure increased consideration and additional disclosures for affected investors.
- Commitment to Legal Services: The firm represents investors globally, focusing on cases of securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, demonstrating their expertise in protecting investor rights.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Lisata Therapeutics, Inc. and Smithfield Foods, Inc., with Lisata shareholders expected to receive $4.00 per share in cash and potential contingent value rights, providing additional revenue opportunities for shareholders.
- Independent Bank Merger: In the merger between Independent Bank Corporation and HCB Financial Corp., HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 in cash per share, which will enhance Independent Bank's market position.
- Sila Realty Sale: In the transaction involving Sila Realty Trust, Inc. and Sunshine Ultimate Parent LLC, Sila Realty shareholders are expected to receive $30.38 in cash per share, delivering substantial cash returns to shareholders.
- Commitment to Legal Services: Monteverde Law Firm is recognized for its successful track record in securities class actions, emphasizing its ability to secure compensation for shareholders, thereby enhancing its competitive edge in the legal services market.
See More
